Dow Jones

38 686,32

1,51%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Juniper Pharmaceuticals, Inc. (delisted) (JNP)
Juniper Pharmaceuticals, Inc. (delisted) (JNP) Actualités

JNP

Juniper Pharmaceuticals, Inc. (JNP)

Juniper Pharmaceuticals, Inc. (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:JNP

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
31/08/2018	16h48	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
31/08/2018	12h23	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
30/08/2018	22h32	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
15/08/2018	22h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
15/08/2018	18h43	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
14/08/2018	23h10	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
14/08/2018	22h59	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
14/08/2018	15h04	Edgar (US Regulatory)	(25-NSE)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
14/08/2018	15h02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
14/08/2018	12h10	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
14/08/2018	12h10	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
09/08/2018	14h46	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
09/08/2018	14h13	PR Newswire (US)	Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
17/07/2018	15h13	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
17/07/2018	14h33	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
09/07/2018	22h58	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
05/07/2018	22h33	PR Newswire (US)	WeissLaw LLP Investigates Juniper Pharmaceuticals, Inc.	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
03/07/2018	16h47	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
03/07/2018	15h07	PR Newswire (US)	Juniper (JNP) Alert: Johnson Fistel Investigates Proposed Sale of Juniper Pharmaceuticals, Inc.; Are Shareholders Getting a F...	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
03/07/2018	09h00	PR Newswire (US)	Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
10/05/2018	13h00	PR Newswire (US)	Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
08/05/2018	17h51	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
01/05/2018	13h00	PR Newswire (US)	Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
30/04/2018	12h24	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
25/04/2018	14h00	PR Newswire (US)	Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
21/03/2018	13h30	PR Newswire (US)	Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
09/03/2018	21h23	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
08/03/2018	14h00	PR Newswire (US)	Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
02/03/2018	13h00	PR Newswire (US)	Juniper Pharmaceuticals to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)
31/01/2018	15h25	PR Newswire (US)	Juniper Pharmaceuticals to Explore Strategic Alternatives	NASDAQ:JNP	Juniper Pharmaceuticals, Inc. (delisted)